The optimal therapy strategy for epidermal growth factor receptor‐mutated non‐small cell lung cancer patients with brain metastasis: A real‐world study from Taiwan

BACKGROUND: The treatment options for epidermal growth factor receptor (EGFR)‐mutated non‐small cell lung cancer (NSCLC) with brain metastases (BMs) include EGFR‐tyrosine kinase inhibitors (TKIs), stereotactic radiosurgery (SRS), whole‐brain radiotherapy, brain surgery, and antiangiogenesis therapy....

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Wen‐Chien, Shen, Yi‐Cheng, Chien, Chun‐Ru, Liao, Wei‐Chih, Chen, Chia‐Hung, Hsia, Te‐Chun, Tu, Chih‐Yeh, Chen, Hung‐Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108041/
https://www.ncbi.nlm.nih.gov/pubmed/35394114
http://dx.doi.org/10.1111/1759-7714.14423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108041/
https://www.ncbi.nlm.nih.gov/pubmed/35394114
http://dx.doi.org/10.1111/1759-7714.14423

Ejemplares similares